HHS Selects Drugs for Medicare Price Negotiation
Biden Administration introduces price regulation to the pharmaceutical industry.
Marketing Formerly Dangerous Drugs
Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.
Negotiating Prices with Drug Manufacturers
The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States.
CMS Confronts an Increase in Medicare Part B Premiums
CMS reconsiders a recent Medicare premium increase after restricting coverage for a controversial new drug.
Value-Pricing Prescription Drugs
Scholar argues that reducing pricing for prescription drugs may increase innovation.
Regulating Drugs at a Discount
Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.
Regulating Prescription Drug Costs
Experts consider how regulators can make drugs affordable without hindering research and development.
Combatting Drug Shortages
A federal task force proposes regulatory solutions to mitigate drug shortages.
Prescription Drug Affordability
The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.